Agilent Technologies agrees takeover of Cartagenia

Agilent Technologies has announced that it will be acquiring the software company Cartagenia in a deal expected to close later this month.

Operating from offices in Belgium and the US, the firm is a leading provider of software and services for clinical genetics and molecular pathology labs, including solutions for variant assessment and reporting of clinical genomics data from next-generation sequencing and microarrays.

Its offerings include the Cartagenia Bench platform, which enables technicians, lab directors and clinicians to visualise, assess and report clinical genetics data in the context of patient information.

Cartagenia employs 36 people, all of whom will now be offered employment by Agilent.

Jacob Thaysen, president of Agilent's diagnostics and genomics group, said: "We look forward to providing Cartagenia's software solutions to our clinical genetics and molecular oncology customers and to providing Cartagenia's existing customers with access to our global service and support network."

Agilent recently instated Mike McMullen as its new chief executive officer, after the long-serving Bill Sullivan chose to step down.